6 Einträge gefunden

1. The novel nomogram of Gleason sum upgrade: possible application for the eligible criteria of low dose rate brachytherapy.

   1. Budäus, Lars
   2. Graefen, Markus
   3. Salomon, Georg
   4. Isbarn, Hendrik
   5. Lughezzani, Giovanni
   6. Sun, Maxine
   7. Chun, Felix

   2010 - Forschungsinformationssystem des UKE
2. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

   1. Walz, Jochen
   2. Haese, Alexander
   3. Scattoni, Vincenzo
   4. Steuber, Thomas
   5. Chun, Felix
   6. Briganti, Alberto
   7. Montorsi, Francesco

   2008 - Forschungsinformationssystem des UKE
3. Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

   1. Chun, Felix
   2. Suardi, Nazareno
   3. Capitanio, Umberto
   4. Jeldres, Claudio
   5. Ahyai, Sascha
   6. Graefen, Markus
   7. Haese, Alexander

   2008 - Forschungsinformationssystem des UKE
4. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.

   1. Schlomm, Thorsten
   2. Kirstein, Patrick
   3. Iwers, Liv
   4. Daniel, Birte
   5. Steuber, Thomas
   6. Walz, Jochen
   7. Chun, Felix

   2007 - Forschungsinformationssystem des UKE
5. Development and external validation of an extended 10-core biopsy nomogram.

   1. Chun, Felix
   2. Briganti, Alberto
   3. Graefen, Markus
   4. Montorsi, Francesco
   5. Porter, Christopher
   6. Scattoni, Vincenzo
   7. Gallina, Andrea

   2007 - Forschungsinformationssystem des UKE
6. Development and external validation of an extended repeat biopsy nomogram.

   1. Chun, Felix
   2. Briganti, Alberto
   3. Graefen, Markus
   4. Porter, Christopher
   5. Montorsi, Francesco
   6. Haese, Alexander
   7. Scattoni, Vincenzo

   2007 - Forschungsinformationssystem des UKE